Granted Patent B2

US 12,509,726 · App. 19/058,911 · Granted Dec 30, 2025

Inventors: Anton Valouev (Palo Alto, CA); Arash Jamshidi (Redwood City, CA)

Assignee: GRAIL, Inc.

C12Q1/6874C12Q1/6869

Abstract

Claims (17)

1 . A composition comprising a dual-indexed nucleic acid library for determining a methylation profile of an individual, comprising a plurality of converted cell-free DNA molecules derived from a biological sample from the individual,

wherein unmethylated cytosines have been converted to uracils in a cell-free nucleic acid molecule of the biological sample and optionally wherein the uracils have been converted to thymines in an amplification product thereof, to produce a converted nucleic acid molecule;

wherein the converted nucleic acid molecule comprises a nucleic acid adapter on the first end and the second end of the converted nucleic acid molecule, wherein each nucleic acid adapter comprises a universal priming site followed by a sample ID sequence used to identify DNA sequences originating from a common source;

wherein the converted nucleic acid molecule is an enrichment target nucleic acid hybridized to a sequence-specific bait nucleic acid, wherein the sequence-specific bait nucleic acid is immobilized on a solid support and is not a PCR primer;

wherein a methylation pattern of the enrichment target nucleic acid is informative of a tumor origin and/or a tissue of origin of the enrichment target nucleic acid,

and wherein the dual-indexed nucleic acid library comprises at least 10 enrichment target nucleic acids hybridized to at least 10 sequence-specific bait nucleic acids immobilized on the solid support.

2 . The composition of claim 1 , wherein the biological sample comprises blood, serum, plasma, urine, cerebral spinal fluid, or lymph.

3 . The composition of claim 1 , wherein the dual-indexed nucleic acid library does not comprise converted nucleic acid molecules that are not enrichment target nucleic acid molecules.

4 . The composition of claim 1 , wherein cell-free DNA molecules from the biological sample were incubated with bisulfite ion or with an enzyme capable of converting unmethylated cytosines to uracils to convert unmethylated cytosines to uracils, optionally, wherein the enzyme is cytidine deaminase.

5 . The composition of claim 1 , wherein the solid support is a bead or is made of a material that allows for recovery by a magnet, centrifugation, or precipitation.

6 . The composition of claim 1 , wherein the methylation profile is used to screen for or diagnose cancer, or wherein the methylation profile is used determine a tissue or origin of cancer.

7 . The composition of claim 1 , wherein the sample ID sequence is used to identify DNA sequences originating from a sample type, a tissue, a patient, or an individual.

8 . The composition of claim 1 , wherein each nucleic acid adapter comprises a P5 sequence or a P7 sequence.

9 . The composition of claim 1 , wherein the nucleic acid adapter on the first end and the second end of the converted nucleic acid molecule comprises a unique nucleic acid sequence used to distinguish between nucleic acid fragments in a sample.

10 . The composition of claim 1 , wherein the nucleic acid adapter on the first end and the second end of the converted nucleic acid molecule comprises a Y adapter.

11 . The composition of claim 1 , wherein the nucleic acid adapter on the first end and the second end of the converted nucleic acid molecule comprises a unique nucleic acid sequence used to discriminate between nucleic acid mutations arising from amplification and mutations induced by conversion of unmethylated cytosines to uracil.

12 . The composition of claim 1 , wherein methylation patterns of enrichment target nucleic acids in the dual-indexed nucleic acid library are determined by sequencing.

Assignments (1)

Continuity (5)

References Cited (140)